Confidential Business Information Contrary to Biosafety

A recent article published in PLOS Biology Journal examines the problems with the current practices and the indiscriminate uses of confidential business information (CBI) claims in biosafety assessments. […]

The Biosafety Clearing House: Considerations and Caveats

What has been achieved with the BCH is remarkable but the BCH is NOT sufficient to all the tasks required under the Cartegena Biosafety Protocol, nor does it contain the reliable and comprehensive information necessary for biosafety decision-making. […]

A Critique of the Biosafety Clearing House

This analysis addresses concerns about the Biosafety Clearing House established under the Cartegena Protocol on Biosafety as it currently exists in “pilot” form. […]